| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |